1. Home
  2. EE vs ORIC Comparison

EE vs ORIC Comparison

Compare EE & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$31.69

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$13.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
ORIC
Founded
2003
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
EE
ORIC
Price
$31.69
$13.61
Analyst Decision
Buy
Strong Buy
Analyst Count
13
16
Target Price
★ $43.46
$21.64
AVG Volume (30 Days)
306.1K
★ 1.4M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
★ 1.09%
N/A
EPS Growth
0.79
★ 19.67
EPS
★ 0.75
N/A
Revenue
★ $1,228,263,000.00
N/A
Revenue This Year
$24.05
N/A
Revenue Next Year
$27.03
N/A
P/E Ratio
$43.95
★ N/A
Revenue Growth
★ 44.26
N/A
52 Week Low
$24.89
$7.23
52 Week High
$43.18
$14.68

Technical Indicators

Market Signals
Indicator
EE
ORIC
Relative Strength Index (RSI) 35.15 59.43
Support Level N/A $13.12
Resistance Level $35.99 $14.22
Average True Range (ATR) 1.22 0.83
MACD -0.05 0.20
Stochastic Oscillator 4.61 79.32

Price Performance

Historical Comparison
EE
ORIC

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: